Analysis Metabolite Name Measured Value Units Cell Type Stimulation
Reversed phase NEGATIVE ION MODEASPARTATE (CAS# 56-84-8); (M-H)-54880Peak areaHAHA IFN-G
Reversed phase NEGATIVE ION MODEASPARTATE (CAS# 56-84-8); (M-H)-60223Peak areaPAK IFN-G
Reversed phase NEGATIVE ION MODEASPARTATE (CAS# 56-84-8); (M-H)-61064Peak areaHAHA Untreated
Reversed phase NEGATIVE ION MODEASPARTATE (CAS# 56-84-8); (M-H)-75486Peak areaHAHA IL-17A
Reversed phase NEGATIVE ION MODEASPARTATE (CAS# 56-84-8); (M-H)-75910Peak areaHAHA TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEASPARTATE (CAS# 56-84-8); (M-H)-112046Peak areaBS4 IFN-G
Reversed phase NEGATIVE ION MODEASPARTATE (CAS# 56-84-8); (M-H)-113729Peak areaPAK TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEASPARTATE (CAS# 56-84-8); (M-H)-132010Peak areaPAK TNF-alpha
Reversed phase NEGATIVE ION MODEASPARTATE (CAS# 56-84-8); (M-H)-137186Peak areaPAK IL-17A
Reversed phase NEGATIVE ION MODEASPARTATE (CAS# 56-84-8); (M-H)-183334Peak areaBS4 Untreated
Reversed phase NEGATIVE ION MODEASPARTATE (CAS# 56-84-8); (M-H)-188242Peak areaPAK Untreated
Reversed phase NEGATIVE ION MODEASPARTATE (CAS# 56-84-8); (M-H)-199873Peak areaBS4 TNF-alpha
Reversed phase NEGATIVE ION MODEASPARTATE (CAS# 56-84-8); (M-H)-203857Peak areaBS4 IL-17A
Reversed phase NEGATIVE ION MODEASPARTATE (CAS# 56-84-8); (M-H)-Peak areaBS4 TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEASPARTATE (CAS# 56-84-8); (M-H)-Peak areaHAHA TNF-alpha
Reversed phase NEGATIVE ION MODEASPARTATE (CAS# 56-84-8); (M+HCOO)-6618Peak areaBS4 TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEASPARTATE (CAS# 56-84-8); (M+HCOO)-Peak areaBS4 IFN-G
Reversed phase NEGATIVE ION MODEASPARTATE (CAS# 56-84-8); (M+HCOO)-Peak areaBS4 IL-17A
Reversed phase NEGATIVE ION MODEASPARTATE (CAS# 56-84-8); (M+HCOO)-Peak areaBS4 TNF-alpha
Reversed phase NEGATIVE ION MODEASPARTATE (CAS# 56-84-8); (M+HCOO)-Peak areaBS4 Untreated
Reversed phase NEGATIVE ION MODEASPARTATE (CAS# 56-84-8); (M+HCOO)-Peak areaHAHA IFN-G
Reversed phase NEGATIVE ION MODEASPARTATE (CAS# 56-84-8); (M+HCOO)-Peak areaHAHA IL-17A
Reversed phase NEGATIVE ION MODEASPARTATE (CAS# 56-84-8); (M+HCOO)-Peak areaHAHA TNF-alpha
Reversed phase NEGATIVE ION MODEASPARTATE (CAS# 56-84-8); (M+HCOO)-Peak areaHAHA TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEASPARTATE (CAS# 56-84-8); (M+HCOO)-Peak areaHAHA Untreated
Reversed phase NEGATIVE ION MODEASPARTATE (CAS# 56-84-8); (M+HCOO)-Peak areaPAK IFN-G
Reversed phase NEGATIVE ION MODEASPARTATE (CAS# 56-84-8); (M+HCOO)-Peak areaPAK IL-17A
Reversed phase NEGATIVE ION MODEASPARTATE (CAS# 56-84-8); (M+HCOO)-Peak areaPAK TNF-alpha
Reversed phase NEGATIVE ION MODEASPARTATE (CAS# 56-84-8); (M+HCOO)-Peak areaPAK TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEASPARTATE (CAS# 56-84-8); (M+HCOO)-Peak areaPAK Untreated

Return to search page
  logo